Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « population »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
popular < population < populations  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 42.
[0-20] [0 - 20][0 - 42][20-40]
Ident.Authors (with country if any)Title
000000 (2009) Susan P. Bruce [États-Unis]Recent Developments in the Treatment of Rheumatoid Arthritis
000013 (2013) Micha Levi [États-Unis] ; Susan Grange [États-Unis] ; Nicolas Frey [Suisse]Exposure‐Exposure Relationship of Tocilizumab, an Anti–IL‐6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis
000021 (2010) Nicolas Frey [Suisse] ; Susan Grange [Suisse] ; Thasia Woodworth [Royaume-Uni]Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis
000022 (2011) Leonid Gibiansky [États-Unis] ; Nicolas Frey [États-Unis]Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach
000173 (2013) Nam Trung Nguyen [Japon, Viêt Nam] ; Taisuke Nakahama [Japon] ; Tadamitsu Kishimoto [Japon]Aryl hydrocarbon receptor and experimental autoimmune arthritis
000181 (2015) Yi Zhang [États-Unis] ; Xiaohui Wei [États-Unis] ; Gaurav Bajaj [États-Unis] ; Jeffrey S. Barrett [États-Unis] ; Bernd Meibohm [États-Unis] ; Amita Joshi [États-Unis] ; Manish Gupta [États-Unis]Challenges and considerations for development of therapeutic proteins in pediatric patients
000189 (2013) Diogo Mendes [Portugal] ; Carlos Alves [Portugal] ; Francisco Batel Marques [Portugal]Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events
000245 (2012) M. Frosch [Allemagne] ; D. Holzinger [Allemagne] ; J. Roth [Allemagne]Systemische Verlaufsform der juvenilen idiopathischen Arthritis
000283 (2011) A. Arman [Turquie] ; A. Coker [Turquie] ; O. Sarioz [Turquie] ; N. Inanc [Turquie] ; H. Direskeneli [Turquie]Lack of association between IL-6 gene polymorphisms and rheumatoid arthritis in Turkish population
000354 (2013) S. C. Horton [Royaume-Uni] ; S. Das [Royaume-Uni] ; D. Bryer [Royaume-Uni] ; P. Emery [Royaume-Uni] ; M. H. Buch [Royaume-Uni]AB0573 Tocilizumab use in a diverse patient population: Single-centre tertiary experience
000382 (2013) M. J. Lim ; S. H. Park [Corée du Sud] ; S.-C. Shim ; H. J. Baek ; D.-H. Yoo ; H. A. Kim ; S. K. Lee ; Y. J. Lee [Corée du Sud] ; Y. E. Park ; H.-S. Cha ; W. Park ; Y.-W. Song [Corée du Sud]AB0562 A double-blind, placebo-controlled, multicenter trial of tocilizumab in moderate to severe active RA patients with inadequate response to methotrexate in korean population
000462 (2013) Reinhard P. T. Rychlik [Allemagne]Target patient population: how does the regulatory and reimbursement view differ? Insights from the German IQWiG
000507 (2013) Todd A. Morrison [États-Unis] ; Mark Figgie [États-Unis] ; Andy O. Miller [États-Unis] ; Susan M. Goodman [États-Unis]Periprosthetic Joint Infection in Patients with Inflammatory Joint Disease: a Review of Risk Factors and Current Approaches to Diagnosis and Management
000510 (2013) H. Pieringer [Autriche] ; U. C. Hoppe [Autriche]Warum die rheumatoide Arthritis den Kardiologen braucht
000535 (2013) Oliver Foot ; Anshuman MalaviyaTreatment of rheumatoid arthritis: current and future
000576 (2013) Marco Bigoni [Italie] ; Paola Sacerdote [Italie] ; Marco Turati [Italie] ; Silvia Franchi [Italie] ; Marta Gandolla [Italie] ; Diego Gaddi [Italie] ; Sarah Moretti [Italie] ; Daniele Munegato [Italie] ; Carlo A. Augusti [Italie] ; Elena Bresciani [Italie] ; Robert J. Omeljaniuk [Canada] ; Vittorio Locatelli [Italie] ; Antonio Torsello [Italie]Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury
000612 (2014) Andrew T. Chow [États-Unis] ; Justin C. Earp [États-Unis] ; Manish Gupta [États-Unis] ; William Hanley [États-Unis] ; Chuanpu Hu [États-Unis] ; Diane D. Wang [États-Unis] ; Stefan Zajic [États-Unis] ; Min Zhu [États-Unis]Utility of population pharmacokinetic modeling in the assessment of therapeutic protein‐drug interactions
000652 (2013) D. Dimopoulou ; M. Trachana ; P. Sidiropoulos ; P. Tsitsi ; A. Moihovitou [Grèce] ; A. GaryfallosSAT0456 Long-Term Outcome in Adult Patients with Juvenile Idiopathic Arthritis: Preliminary Results from a Greek Population
000875 (2012) Nicolino Ruperto [Italie] ; Pierre Quartier [France] ; Nico Wulffraat [Pays-Bas] ; Patricia Woo [Royaume-Uni] ; Angelo Ravelli [Italie] ; Richard Mouy [France] ; Brigitte Bader-Meunier [France] ; Sebastiaan J. Vastert [Pays-Bas] ; Emanuele Noseda [Suisse] ; Daniele D'Ambrosio [Suisse] ; Jean Lecot [Suisse] ; Abhijit Chakraborty [Suisse] ; Alberto Martini [Italie] ; Andrea Chioato [Suisse]A phase II, multicenter, open‐label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
000A42 (2012) Meryem Can [Turquie] ; Fatma Alibaz-Öner [Turquie] ; Sibel Y Lmaz-Öner [Turquie] ; Pamir Atagündüz [Turquie] ; Nevsun Nanç [Turquie] ; Haner Direskeneli [Turquie]Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience
000B67 (2012) Sandeep Kumar [États-Unis] ; Mark A. Mitchell [États-Unis] ; Bonita Rup [États-Unis] ; Satish K. Singh [États-Unis]Relationship between potential aggregation‐prone regions and HLA‐DR‐binding T‐cell immune epitopes: Implications for rational design of novel and follow‐on therapeutic antibodies

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "population" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "population" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    population
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021